147 related articles for article (PubMed ID: 24237447)
1. Oncogenic deregulation of NKL homeobox gene MSX1 in mantle cell lymphoma.
Nagel S; Ehrentraut S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Leuk Lymphoma; 2014 Aug; 55(8):1893-903. PubMed ID: 24237447
[TBL] [Abstract][Full Text] [Related]
2. Repressed BMP signaling reactivates NKL homeobox gene MSX1 in a T-ALL subset.
Nagel S; Ehrentraut S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Leuk Lymphoma; 2015 Feb; 56(2):480-91. PubMed ID: 24844359
[TBL] [Abstract][Full Text] [Related]
3. Deregulated FOX genes in Hodgkin lymphoma.
Nagel S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Genes Chromosomes Cancer; 2014 Nov; 53(11):917-33. PubMed ID: 25043849
[TBL] [Abstract][Full Text] [Related]
4. NKL homeobox gene activities in hematopoietic stem cells, T-cell development and T-cell leukemia.
Nagel S; Pommerenke C; Scherr M; Meyer C; Kaufmann M; Battmer K; MacLeod RA; Drexler HG
PLoS One; 2017; 12(2):e0171164. PubMed ID: 28151996
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional deregulation of homeobox gene ZHX2 in Hodgkin lymphoma.
Nagel S; Schneider B; Meyer C; Kaufmann M; Drexler HG; Macleod RA
Leuk Res; 2012 May; 36(5):646-55. PubMed ID: 22078940
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma.
Nagel S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Oncotarget; 2015 Nov; 6(37):40112-26. PubMed ID: 26473286
[TBL] [Abstract][Full Text] [Related]
7. NKL homeobox gene activities in B-cell development and lymphomas.
Nagel S; MacLeod RAF; Meyer C; Kaufmann M; Drexler HG
PLoS One; 2018; 13(10):e0205537. PubMed ID: 30308041
[TBL] [Abstract][Full Text] [Related]
8. High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma.
Islam TC; Asplund AC; Lindvall JM; Nygren L; Liden J; Kimby E; Christensson B; Smith CI; Sander B
Leukemia; 2003 Sep; 17(9):1880-90. PubMed ID: 12970790
[TBL] [Abstract][Full Text] [Related]
9. NKL homeobox gene activities in normal and malignant myeloid cells.
Nagel S; Scherr M; MacLeod RAF; Pommerenke C; Koeppel M; Meyer C; Kaufmann M; Dallmann I; Drexler HG
PLoS One; 2019; 14(12):e0226212. PubMed ID: 31825998
[TBL] [Abstract][Full Text] [Related]
10. Deregulated expression of NKL homeobox genes in T-cell lymphomas.
Nagel S; Pommerenke C; MacLeod RAF; Meyer C; Kaufmann M; Fähnrich S; Drexler HG
Oncotarget; 2019 May; 10(35):3227-3247. PubMed ID: 31143370
[TBL] [Abstract][Full Text] [Related]
11. The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta-Notch pathway in neuroblastoma.
Revet I; Huizenga G; Chan A; Koster J; Volckmann R; van Sluis P; Øra I; Versteeg R; Geerts D
Exp Cell Res; 2008 Feb; 314(4):707-19. PubMed ID: 18201699
[TBL] [Abstract][Full Text] [Related]
12. NKL homeobox gene MSX1 acts like a tumor suppressor in NK-cell leukemia.
Nagel S; Pommerenke C; Meyer C; Kaufmann M; MacLeod RAF; Drexler HG
Oncotarget; 2017 Sep; 8(40):66815-66832. PubMed ID: 28977998
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of polycomb repressor complex 1 modifier AUTS2 in T-cell leukemia.
Nagel S; Pommerenke C; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Oncotarget; 2016 Jul; 7(29):45398-45413. PubMed ID: 27322685
[TBL] [Abstract][Full Text] [Related]
14. LIM homeobox transcription factor Lhx2 inhibits skeletal muscle differentiation in part via transcriptional activation of Msx1 and Msx2.
Kodaka Y; Tanaka K; Kitajima K; Tanegashima K; Matsuda R; Hara T
Exp Cell Res; 2015 Feb; 331(2):309-19. PubMed ID: 25460335
[TBL] [Abstract][Full Text] [Related]
15. The Wnt signaling pathway and mitotic regulators in the initiation and evolution of mantle cell lymphoma: Gene expression analysis.
Kimura Y; Arakawa F; Kiyasu J; Miyoshi H; Yoshida M; Ichikawa A; Niino D; Sugita Y; Okamura T; Doi A; Yasuda K; Tashiro K; Kuhara S; Ohshima K
Int J Oncol; 2013 Aug; 43(2):457-68. PubMed ID: 23760751
[TBL] [Abstract][Full Text] [Related]
16. Identification of miR-15b as a transformation-related factor in mantle cell lymphoma.
Arakawa F; Kimura Y; Yoshida N; Miyoshi H; Doi A; Yasuda K; Nakajima K; Kiyasu J; Niino D; Sugita Y; Tashiro K; Kuhara S; Seto M; Ohshima K
Int J Oncol; 2016 Feb; 48(2):485-92. PubMed ID: 26676972
[TBL] [Abstract][Full Text] [Related]
17. Aberrantly Expressed OTX Homeobox Genes Deregulate B-Cell Differentiation in Hodgkin Lymphoma.
Nagel S; Ehrentraut S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
PLoS One; 2015; 10(9):e0138416. PubMed ID: 26406991
[TBL] [Abstract][Full Text] [Related]
18. NKL homeobox gene NKX2-2 is aberrantly expressed in Hodgkin lymphoma.
Nagel S; MacLeod RAF; Pommerenke C; Meyer C; Kaufmann M; Drexler HG
Oncotarget; 2018 Dec; 9(101):37480-37496. PubMed ID: 30680064
[TBL] [Abstract][Full Text] [Related]
19. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
[TBL] [Abstract][Full Text] [Related]
20. NKL Homeobox Genes NKX2-3 and NKX2-4 Deregulate Megakaryocytic-Erythroid Cell Differentiation in AML.
Nagel S; Pommerenke C; Meyer C; MacLeod RAF
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
